Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degenerationMisa Suzuki, Yoko Ozawa, Norihiro Nagai et al.|British Journal of Ophthalmology|2014Cited by 99
Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachmentNorihiro Nagai, Yoko Ozawa, Misa Suzuki et al.|Scientific Reports|2016Cited by 60
Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathyNorihiro Nagai, Yoko Ozawa, Misa Suzuki et al.|Scientific Reports|2019Cited by 35
Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practiceShinri Sato, Yoko Ozawa, Hajime Shinoda et al.|Medicine|2017Cited by 25
Macular Pigment Optical Density and Photoreceptor Outer Segment Length as Predisease Biomarkers for Age-Related Macular DegenerationNorihiro Nagai, Yoko Ozawa, Kazuhiro Watanabe et al.|Journal of Clinical Medicine|2020Cited by 25